These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6473149)

  • 21. Synthesis, cloning and expression in Escherichia coli of artificial genes coding for biologically active elongated precursors of the vasoactive intestinal polypeptide.
    Simoncsits A; Tjörnhammar ML; Kalman M; Cserpan I; Gafvelin G; Bartfai T
    Eur J Biochem; 1988 Dec; 178(2):343-50. PubMed ID: 3145201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iodinated derivatives of vasoactive intestinal peptide (VIP), PHI and PHM: purification, chemical characterization and biological activity.
    McMaster D; Suzuki Y; Rorstad O; Lederis K
    Peptides; 1987; 8(4):663-76. PubMed ID: 3628082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification of monoiodinated vasointestinal peptide (M125I-VIP) by high pressure liquid chromatography (HPLC).
    Marie JC; Boissard C; Rosselin G
    Peptides; 1984; 5(2):179-82. PubMed ID: 6089129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and amino acid composition of human vasoactive intestinal polypeptide (VIP).
    Carlquist M; McDonald TJ; Go VL; Bataille D; Johansson C; Mutt V
    Horm Metab Res; 1982 Jan; 14(1):28-9. PubMed ID: 7061035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immuno-affinity purification of specific antibodies against vasoactive intestinal polypeptide (VIP) on VIP (1-10)-linked polydimethylacrylamide resin.
    Takeyama M; Hatano M; Otaka A; Fujii N; Yajima H
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):834-7. PubMed ID: 2752498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasoactive intestinal polypeptide carboxy-terminal fragment, VIP(22-28), and other fragments of VIP, in the central nervous system of the rat.
    Romualdi P; Rosenberger JG; Gozzini L; Cox BM
    Peptides; 1989; 10(3):621-6. PubMed ID: 2780421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiosynthesis of 18F-(R8,15,21, L17)-vasoactive intestinal peptide and preliminary evaluation in mice bearing C26 colorectal tumours.
    Cheng D; Yin D; Zhang L; Wang M; Li G; Wang Y
    Nucl Med Commun; 2007 Jun; 28(6):501-6. PubMed ID: 17460542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The preparation of biotinyl-epsilon-aminocaproylated forms of the vasoactive intestinal polypeptide (VIP) as probes for the VIP receptor.
    Andersson M; Marie JC; Carlquist M; Mutt V
    FEBS Lett; 1991 Apr; 282(1):35-40. PubMed ID: 1851109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concentrations and distribution of vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI) and peptide histidine valine (PHV) in the cerebral cortex and the suprachiasmatic nucleus of the mouse.
    Mikkelsen JD; Fahrenkrug J
    Brain Res; 1994 Sep; 656(1):95-107. PubMed ID: 7804850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of VIP on guinea pig taenia coli requires the whole sequence.
    Pipkorn R; Håkanson R
    Peptides; 1984; 5(2):267-9. PubMed ID: 6473155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the relaxant effects of vasoactive intestinal peptide (VIP) and PHI on isolated brain arteries.
    Suzuki Y; McMaster D; Lederis K; Rorstad OP
    Brain Res; 1984 Nov; 322(1):9-16. PubMed ID: 6549149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of a hydrophilic affinity matrix for the purification of the vasoactive intestinal peptide receptor.
    Fournier A; Couvineau A; Laburthe M
    Anal Biochem; 1993 Jun; 211(2):305-10. PubMed ID: 8391225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Affinity chromatography of catalytic autoantibody to vasoactive intestinal peptide.
    Paul S; Volle DJ; Mei S
    J Immunol; 1990 Aug; 145(4):1196-9. PubMed ID: 2380555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C; Bawab W; de Cremoux P; Calvo F
    Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of helix-based vasoactive intestinal peptide analogues: identification of residues required for receptor interaction.
    Musso GF; Patthi S; Ryskamp TC; Provow S; Kaiser ET; Veliçelebi G
    Biochemistry; 1988 Oct; 27(21):8174-81. PubMed ID: 2852954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Porcine VIP is more potent than guinea pig VIP in relaxing the guinea pig uterine artery.
    Morris JL; Murphy R
    Peptides; 1989; 10(4):887-9. PubMed ID: 2587428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasoactive intestinal polypeptide is synthesized in anterior pituitary tissue.
    Arnaout MA; Garthwaite TL; Martinson DR; Hagen TC
    Endocrinology; 1986 Nov; 119(5):2052-7. PubMed ID: 3769861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel vasoactive intestinal peptide (VIP) from elasmobranch intestine has full affinity for mammalian pancreatic VIP receptors.
    Dimaline R; Young J; Thwaites DT; Lee CM; Shuttleworth TJ; Thorndyke MC
    Biochim Biophys Acta; 1987 Aug; 930(1):97-100. PubMed ID: 2441759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin.
    Andersson M; Carlquist M; Maletti M; Marie JC
    FEBS Lett; 1993 Feb; 318(1):35-40. PubMed ID: 8382169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of functional receptors for vasoactive intestinal peptide in bovine cerebral arteries.
    Suzuki Y; McMaster D; Huang M; Lederis K; Rorstad OP
    J Neurochem; 1985 Sep; 45(3):890-9. PubMed ID: 2993516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.